CPRX vs. CL
Compare and contrast key facts about Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CPRX or CL.
Key characteristics
| CPRX | CL | |
|---|---|---|
| YTD Return | 35.63% | 16.77% |
| 1Y Return | 70.40% | 21.42% |
| 3Y Return (Ann) | 45.59% | 7.84% |
| 5Y Return (Ann) | 38.86% | 9.09% |
| 10Y Return (Ann) | 24.02% | 5.47% |
| Sharpe Ratio | 1.88 | 1.46 |
| Sortino Ratio | 2.56 | 1.99 |
| Omega Ratio | 1.33 | 1.27 |
| Calmar Ratio | 2.15 | 1.36 |
| Martin Ratio | 8.57 | 5.26 |
| Ulcer Index | 9.39% | 4.29% |
| Daily Std Dev | 42.75% | 15.44% |
| Max Drawdown | -94.25% | -58.91% |
| Current Drawdown | -4.72% | -15.85% |
Fundamentals
| CPRX | CL | |
|---|---|---|
| Market Cap | $2.75B | $74.76B |
| EPS | $1.18 | $3.48 |
| PE Ratio | 19.53 | 26.29 |
| PEG Ratio | 0.00 | 2.08 |
| Total Revenue (TTM) | $458.21M | $20.11B |
| Gross Profit (TTM) | $376.80M | $12.12B |
| EBITDA (TTM) | $202.05M | $5.13B |
Correlation
The correlation between CPRX and CL is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CPRX vs. CL - Performance Comparison
In the year-to-date period, CPRX achieves a 35.63% return, which is significantly higher than CL's 16.77% return. Over the past 10 years, CPRX has outperformed CL with an annualized return of 24.02%, while CL has yielded a comparatively lower 5.47% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CPRX vs. CL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CPRX vs. CL - Dividend Comparison
CPRX has not paid dividends to shareholders, while CL's dividend yield for the trailing twelve months is around 2.17%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CL Colgate-Palmolive Company | 2.17% | 2.40% | 2.36% | 2.10% | 2.05% | 2.48% | 2.79% | 2.11% | 2.37% | 2.25% | 2.05% | 2.04% |
Drawdowns
CPRX vs. CL - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, which is greater than CL's maximum drawdown of -58.91%. Use the drawdown chart below to compare losses from any high point for CPRX and CL. For additional features, visit the drawdowns tool.
Volatility
CPRX vs. CL - Volatility Comparison
Catalyst Pharmaceuticals, Inc. (CPRX) has a higher volatility of 7.60% compared to Colgate-Palmolive Company (CL) at 6.73%. This indicates that CPRX's price experiences larger fluctuations and is considered to be riskier than CL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CPRX vs. CL - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Colgate-Palmolive Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities